Treatments and Outcomes of Pediatric Head and Neck Lymphatic Malformations: A 20‐Year Single Institution Experience
Otolaryngology–Head and Neck Surgery · 2025
DOI: 10.1002/ohn.1077 ↗At a glance
Journal article in Otolaryngology–Head and Neck Surgery, 2025. Written by Jared Zhao and 3 co-authors. Institution: Johns Hopkins University School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA. Major MEDLINE topics: Lymphatic Abnormalities. Cited 8 times so far (Crossref); 32 references. The full text is freely available in PubMed Central. Funded by: NIDCD NIH HHS.
Abstract (original language)
Objective
Examine the management and outcomes of pediatric head and neck lymphatic malformations (HNLMs). Study Design Retrospective case series.
Setting
Tertiary academic hospital.
Methods
Patients aged 18 years or younger treated for HNLMs at Johns Hopkins Hospital from 2000 to 2023 were identified. Demographics, clinical characteristics, and treatment courses were recorded from charts. Outcome measures included estimated clinical post‐treatment size reduction and complications. Fisher's exact test was performed for comparisons between treatments.
Results
We identified 101 pediatric patients (50.5% female) with HNLMs. Fifty‐two received unimodal treatment, 11 received multimodal treatment, and 38 underwent active observation or no treatment. Of those who received treatment, 44% had their first treatment before 2 years of age. 54.5% of all patients received sclerotherapy. Sclerotherapy caused nearly complete or complete resolution in 52.2% (n = 24) of low‐stage (de Serres Stages 1‐3) HNLMs and complete resolution in 26.1%. Most (71.4%) high‐stage (de Serres Stages 4‐5) malformations demonstrated limited size reduction response to all treatments. Surgery had a higher all‐inclusive complication rate (25%) compared to sclerotherapy (17%). Multimodal treatment strategies were most often used to treat microcystic malformations of all stages, achieving a 42.9% nearly complete or complete resolution rate.
Conclusion
Low‐stage and macrocystic pediatric HNLMs respond well to treatment. Sclerotherapy had the lowest complication rate. High‐stage malformations had limited size reduction response to multimodal treatment. As new medical therapies continue to develop, opportunities for improved treatment algorithms will emerge.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Johns Hopkins University School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
- Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, Baltimore, Maryland, USA.
- Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland, USA.
ORCID profiles: Jared Zhao, Elaine Thompson, Clifford Raabe Weiss
Funding
- NIDCD NIH HHS
Cite
APA
Zhao, J., Thompson, E., Weiss, C. R., & Walsh, J. (2025). Treatments and Outcomes of Pediatric Head and Neck Lymphatic Malformations: A 20‐Year Single Institution Experience. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1077
Vancouver
Zhao J, Thompson E, Weiss CR, Walsh J. Treatments and Outcomes of Pediatric Head and Neck Lymphatic Malformations: A 20‐Year Single Institution Experience. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.1077
BibTeX
@article{Zhao2025,
author = {Zhao, Jared and Thompson, Elaine and Weiss, Clifford Raabe and Walsh, Jonathan},
title = {Treatments and Outcomes of Pediatric Head and Neck Lymphatic Malformations: A 20‐Year Single Institution Experience},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2025},
doi = {10.1002/ohn.1077}
}
EUVIMED